Holen Sie sich die Stockscreener-App
4.25
3.85%
-0.17
Handel nachbörslich:
4.17
-0.08
-1.88%
Schlusskurs vom Vortag:
$4.42
Offen:
$4.4
24-Stunden-Volumen:
2.31M
Relative Volume:
2.20
Marktkapitalisierung:
$814.72M
Einnahmen:
$12.99M
Nettoeinkommen (Verlust:
$-74.39M
KGV:
-9.6591
EPS:
-0.44
Netto-Cashflow:
$-78.92M
1W Leistung:
-4.71%
1M Leistung:
+21.78%
6M Leistung:
+28.40%
1J Leistung:
+2.66%
1-Tages-Spanne:
$4.175
$4.435
1-Wochen-Bereich:
$4.175
$4.57
52-Wochen-Spanne:
$2.705
$5.10
Arbutus Biopharma Corp Stock (ABUS) Company Profile
Firmenname
Arbutus Biopharma Corp
Sektor
Branche
Telefon
604-419-3200
Adresse
701 VETERANS CIRCLE, WARMINSTER, PA
Vergleichen Sie ABUS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ABUS
Arbutus Biopharma Corp
|
4.25 | 847.31M | 12.99M | -74.39M | -78.92M | -0.44 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.12 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
591.99 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
736.76 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
334.40 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
Arbutus Biopharma Corp Stock (ABUS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-02-02 | Hochstufung | Jefferies | Hold → Buy |
| 2021-02-25 | Eingeleitet | Jefferies | Hold |
| 2020-12-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-07-27 | Fortgesetzt | JMP Securities | Mkt Outperform |
| 2020-07-24 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-05-19 | Hochstufung | Wedbush | Neutral → Outperform |
| 2020-03-06 | Hochstufung | Chardan Capital Markets | Neutral → Buy |
| 2020-02-20 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-02-05 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-10-07 | Bestätigt | B. Riley FBR | Buy |
| 2019-10-04 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2018-10-16 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2018-10-15 | Hochstufung | Wedbush | Underperform → Neutral |
| 2018-10-12 | Bestätigt | Chardan Capital Markets | Buy |
| 2018-07-06 | Herabstufung | B. Riley FBR, Inc. | Buy → Neutral |
| 2018-03-19 | Fortgesetzt | Chardan Capital Markets | Buy |
| 2018-03-19 | Herabstufung | Wedbush | Outperform → Neutral |
| 2018-01-05 | Eingeleitet | B. Riley FBR, Inc. | Buy |
| 2017-04-04 | Hochstufung | Chardan Capital Markets | Neutral → Buy |
| 2017-02-01 | Bestätigt | Wedbush | Outperform |
| 2016-12-13 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2016-11-30 | Hochstufung | Chardan Capital Markets | Neutral → Buy |
Alle ansehen
Arbutus Biopharma Corp Aktie (ABUS) Neueste Nachrichten
What machine learning models say about Arbutus Biopharma Corporation2025 Key Lessons & AI Based Buy/Sell Signal Reports - newser.com
Building trade automation scripts for Arbutus Biopharma CorporationTake Profit & Weekly Breakout Watchlists - newser.com
Arbutus Biopharma Corporation stock volume spike explainedQuarterly Risk Review & High Win Rate Trade Alerts - newser.com
Is Arbutus Biopharma Corporation stock bottoming outLong Setup & Weekly Setup with ROI Potential - newser.com
what machine learning models say about arbutus biopharma corporationJuly 2025 PreEarnings & Risk Controlled Daily Plans - newser.com
Is Arbutus Biopharma Corporation reversing from oversold territoryOptions Play & Weekly Return Optimization Plans - newser.com
Using economic indicators to assess Arbutus Biopharma Corporation potential2025 Market WrapUp & Stepwise Trade Signal Guides - newser.com
Aug Setups: Whats next for Arbutus Biopharma Corporation stockLong Setup & Weekly Breakout Watchlists - khodrobank.com
Reversal indicators forming on Arbutus Biopharma Corporation stockQuarterly Growth Report & Fast Entry Momentum Trade Alerts - newser.com
Analyzing drawdowns of Arbutus Biopharma Corporation with statistical tools2025 Technical Patterns & Expert Approved Momentum Ideas - newser.com
What MACD signals say about Arbutus Biopharma CorporationAnalyst Upgrade & Technical Pattern Based Signals - newser.com
Arbutus Biopharma Corporation $ABUS Shares Purchased by Goldman Sachs Group Inc. - MarketBeat
Aug Rallies: Is Arbutus Biopharma Corporation stock a top performer YTD2025 Price Action Summary & Technical Pattern Based Signals - خودرو بانک
RSI Check: Should I set a stop loss on RELYMarket Performance Report & Free Community Consensus Stock Picks - خودرو بانک
Arbutus: IP Drama With High Stakes (NASDAQ:ABUS) - Seeking Alpha
Fundamentals Check: What’s next for Arbutus Biopharma Corporation stockWeekly Volume Report & Risk Controlled Daily Trade Plans - khodrobank.com
Has Arbutus Biopharma Corporation formed a bullish divergenceCEO Change & Weekly Market Pulse Updates - newser.com
Published on: 2025-09-15 00:38:22 - newser.com
is arbutus biopharma corporation reversing from oversold territory2025 Short Interest & Daily Risk Controlled Trade Plans - newser.com
Arbutus Biopharma (NASDAQ:ABUS) Stock Price Down 4.6%What's Next? - MarketBeat
Arbutus Biopharma Corporation stock retracement – recovery analysisQuarterly Growth Report & Expert Approved Momentum Ideas - newser.com
Arbutus Biopharma (NASDAQ:ABUS) Trading Up 6.4%Still a Buy? - MarketBeat
Is Arbutus Biopharma Corporation showing signs of accumulationQuarterly Portfolio Report & Expert Approved Momentum Ideas - Newser
Adage Capital Partners GP L.L.C. Cuts Stake in Arbutus Biopharma Corporation $ABUS - MarketBeat
What to expect from Arbutus Biopharma Corporation in the next 30 daysQuarterly Trade Summary & Daily Entry Point Alerts - Newser
Arbutus Biopharma (NASDAQ:ABUS) Hits New 1-Year HighStill a Buy? - MarketBeat
Relative strength of Arbutus Biopharma Corporation in sector analysisTrade Entry Report & Long-Term Investment Growth Plans - Newser
Combining price and volume data for Arbutus Biopharma CorporationDollar Strength & Reliable Intraday Trade Alerts - Newser
How institutional ownership impacts Arbutus Biopharma Corporation stockPortfolio Performance Summary & Weekly Market Pulse Alerts - Newser
Key resistance and support levels for Arbutus Biopharma CorporationJuly 2025 Selloffs & Short-Term High Return Ideas - Newser
Invesco Ltd. Has $487,000 Stock Holdings in Arbutus Biopharma Corporation $ABUS - MarketBeat
Two Seas Capital LP Acquires 725,000 Shares of Arbutus Biopharma Corporation $ABUS - MarketBeat
Chart based analysis of Arbutus Biopharma Corporation trendsWeekly Trend Summary & AI Powered Market Trend Analysis - Newser
Combining machine learning predictions for Arbutus Biopharma CorporationMarket Growth Review & AI Driven Price Forecasts - Newser
Is Arbutus Biopharma Corporation forming a bottoming baseWeekly Profit Report & Long-Term Capital Growth Ideas - Newser
Finanzdaten der Arbutus Biopharma Corp-Aktie (ABUS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.43%
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):